Magnesium Sulfate May Reduce Risk of Cerebral Palsy

While babies can develop cerebral palsy a number of different ways, including as a result of medical negligence during birth, premature babies have a significantly higher risk of developing the developmental disorder than babies carried full-term. In fact, about a third of all cases of cerebral palsy occur in pre-term births. Evidence from a new Cochrane Review study, however, indicates that treating women at risk of very preterm birth with magnesium sulfate may increase the baby’s chance of being born free of cerebral palsy by as much as 32 percent. The treatment was also found to decrease the chance of developing other major movement disabilities by 39 percent.

Read more about the magnesium sulfate study here.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers
Contact Information